1-11 of 11
Elliott Winton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Updated Analysis on Safety and Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis from the Explorer Clinical Study: Long-Term Efficacy and Safety

Daniel J. DeAngelo, Deepti H. Radia, Tracy I. George, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott Winton, Hans-Peter Horny, Meera Tugnait, Hui-Min Lin, Saša Dimitrijević, Javier I. Munoz-Gonzalez, Ilda Bidollari, Michael W. Deininger, Jason Gotlib
Journal: Blood
Blood (2022) 140 (Supplement 1): 3932–3934.
https://doi.org/10.1182/blood-2022-167593
Published: 2022
Journal Articles

Efficacy and Safety of Add-on Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Suboptimal Response to Ruxolitinib: Final Results From a Phase 2 Study

Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice Wang, Aaron T. Gerds, Gabriela S. Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2022) 140 (Supplement 1): 579–582.
https://doi.org/10.1182/blood-2022-160384
Published: 2022
Journal Articles

Subgroup Analysis from a Phase 2 Study of the Efficacy and Safety of Parsaclisib, a Selective PI3Kδ Inhibitor, in Combination with Ruxolitinib in Patients with Myelofibrosis (MF)

Abdulraheem Yacoub, Uma Borate, Raajit Rampal, Haris Ali, Eunice S. Wang, Aaron T. Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 3647.
https://doi.org/10.1182/blood-2021-148668
Published: 2021
Journal Articles

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Clinical Trials & Observations
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, Josef T. Prchal, Dmitry Berenzon, Maria R. Baer, Ellen Ritchie, Richard T. Silver, Craig Kessler, Elliott Winton, Maria Chiara Finazzi, Alessandro Rambaldi, Alessandro M. Vannucchi, David Leibowitz, Damiano Rondelli, Murat O. Arcasoy, Rosalind Catchatourian, Joseph Vadakara, Vittorio Rosti, Elizabeth Hexner, Marina Kremyanskaya, Lonette Sandy, Joseph Tripodi, Vesna Najfeld, Noushin Farnoud, Elli Papaemmanuil, Mohamed Salama, Rona Singer-Weinberg, Raajit Rampal, Judith D. Goldberg, Tiziano Barbui, Ruben Mesa, Amylou C. Dueck, Ronald Hoffman
Journal: Blood
Blood (2019) 134 (18): 1498–1509.
https://doi.org/10.1182/blood.2019000428
Published: 2019
Includes: Supplemental data
Journal Articles

Primary Analysis Results from an Open-Label Phase II Study of INCB039110, a Selective JAK1 Inhibitor, in Patients with Myelofibrosis

John O Mascarenhas, MD MS, Moshe Talpaz, Vikas Gupta, MD FRCP, FRCPath, Lynda M Foltz, MD FRCP, Michael R Savona, MD, Ron Paquette, MD, Robert Turner, MD, Paul Coughlin, PhD MBBS, Elliott Winton, MD, Deborah Hunter, PhD, Albert Assad, MD, Jason Clark, PhD, Peter O'Neill, MBA, CCRP, Ronald Hoffman, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2014) 124 (21): 714.
https://doi.org/10.1182/blood.V124.21.714.714
Published: 2014
Journal Articles

An Open-Label, Phase II Study Of The JAK1 Inhibitor INCB039110 In Patients With Myelofibrosis

John Mascarenhas, MD, Moshe Talpaz, MD, Vikas Gupta, MD, FRCP, FRCPath, Michael Savona, MD, FACP, Paul Coughlin, FRACP, PhD, Elliott Winton, MD, Deborah Hunter, PhD, Bijoyesh Mookerjee, MD, FACP, Lance Leopold, MD, Jason Clark, PhD, Peter O'Neill, MBA, CCRP, Ronald Hoffman, MD, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 663.
https://doi.org/10.1182/blood.V122.21.663.663
Published: 2013
Journal Articles

Copper Deficiency Remains An Underappreciated Cause of Ineffective Hematopoiesis

Amelia Langston, MD, Jessica Neely, PA, Leonard Heffner, D. Griffith, Martha Arellano, MD, Gregory Esper, MD, Morgan L. McLemore, MD, Thomas Ziegler, MD, Christine Kempton, MD, Rajni Sinha, MD, H. Jean Khoury, MD, Elliott Winton
Journal: Blood
Blood (2008) 112 (11): 3094.
https://doi.org/10.1182/blood.V112.11.3094.3094
Published: 2008
Journal Articles

Patient Characteristics in CD 20 + and CD 20 − Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis.

Sara P. Gladney, MD, Leonard T. Heffner, MD, Amelia Langston, MD, Jeannine Holden, MD, Carol Phillips, MD, Elliott Winton, MD, Christopher R. Flowers, MD, Mary Jo Lechowicz, MD, Sagar Lonial, MD, Edmund Waller, MD, PhD, Hanna J. Khoury, MD
Journal: Blood
Blood (2005) 106 (11): 4523.
https://doi.org/10.1182/blood.V106.11.4523.4523
Published: 2005
Journal Articles

Decreased Incidence of Relapse in Patients with Acute Leukemia Transplanted from Matched Unrelated Donors: Induction of GvL.

Martha L. Arellano, MD, Amelia Langston, MD, Sagar Lonial, MD, Christopher Flowers, MD, Jean H. Khoury, MD, Elliott Winton, MD, Edmund K. Waller, MD, Lechowicz J. Mary, MD
Journal: Blood
Blood (2005) 106 (11): 2016.
https://doi.org/10.1182/blood.V106.11.2016.2016
Published: 2005
Journal Articles

Prognostic Significance of Early Peripheral Blood Blasts Clearance Following Induction Chemotherapy for Adult Acute Myeloid Leukemia.

Suchita Pakkala, MD, Elliott Winton, MD, Amelia Langston, MD, Leonard T. Heffner, MD, Hanna J. Khoury, MD
Journal: Blood
Blood (2005) 106 (11): 4631.
https://doi.org/10.1182/blood.V106.11.4631.4631
Published: 2005
Journal Articles

CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl–positive human leukemia cells to apoptosis due to antileukemic drugs

Guofu Fang, Caryn Naekyung Kim, Charles L. Perkins, Nimmanapalli Ramadevi, Elliott Winton, Sylvie Wittmann, Kapil N. Bhalla
Journal: Blood
Blood (2000) 96 (6): 2246–2253.
https://doi.org/10.1182/blood.V96.6.2246
Published: 2000